EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”

Fabio Salvatore Macaluso, Ambrogio Orlando

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2023.11.001 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Fabio Salvatore Macaluso und 1 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy. Electronic address: fsmacaluso@gmail.com. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansPyrimidinesPiperidinesTreatment OutcomePyrroles

Substanzen

tofacitinibPyrimidinesPiperidinesPyrroles

Autor:innen und Institutionen

  • IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy. Electronic address: fsmacaluso@gmail.com.
  • IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.

Zitieren

APA

Macaluso, F. S., & Orlando, A. (2024). Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.11.001

Vancouver

Macaluso FS, Orlando A. Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2023.11.001

BibTeX
@article{Macaluso2024,
  author = {Macaluso, Fabio Salvatore and Orlando, Ambrogio},
  title = {Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2023.11.001}
}
Kostenlos starten →